Multiple spinal canal and spinal cord meningioma

Summary

Multiple spinal canal and spinal cord meningioma (MONDO:0004317) is a disease. A subtype of intraspinal meningioma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	multiple spinal canal and spinal cord meningioma
Mondo ID	MONDO:0004317
DOID	DOID:7646
NCIT	C5275
UMLS	C1334825
MedGen	235341
GARD	0023930
Is cancer (heuristic)	no

Also known as: multiple intraspinal Meningiomas · multiple Meningiomas of spinal canal and spinal cord · multiple spinal canal and spinal cord Meningiomas

Disease family

This is a subtype of intraspinal meningioma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › central nervous system neoplasm › tumor of meninges › meningioma › intraspinal meningioma › multiple spinal canal and spinal cord meningioma

Related subtypes (6): spinal meningioma, epidural spinal canal meningioma, thoracic spinal canal and spinal cord meningioma, lumbar spinal canal and spinal cord meningioma, cervical spinal canal and spinal cord meningioma, sacral spinal canal and spinal cord meningioma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.